CAF-derived FGFs can activate FGFRs on tumor cells (e.g., in CWR-R1 and LNCaP) and also act autocrinely on CAFs to sustain an activated phenotype characterized by α-SMA expression and increased ECM synthesis. Here, ACTA1 is linked to neoplasm.